Testosterone enhances dopamine depletion by methamphetamine in male, but not female, mice

Neuroscience Letters

Volumn 448, Issue 1, 2008, Pages 130-133

  Lewis, Chandani ^a   Dluzen, Dean E ^a  

^a Northeastern Ohio Medical University   (United States)

Author keywords

Gonadal steroids; Neurodegeneration; Neurotoxicity; Nigrostriatal; Parkinson's disease; Sex differences

Indexed keywords

DOPAMINE; METHAMPHETAMINE; TESTOSTERONE PROPIONATE;

ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GONADECTOMY; MALE; MOUSE; NERVE DEGENERATION; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SEX DIFFERENCE; STRIATE CORTEX;

ANIMALS; CASTRATION; CORPUS STRIATUM; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; METHAMPHETAMINE; MICE; SEX CHARACTERISTICS; TESTOSTERONE PROPIONATE;

EID: 55749105287     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.10.011     Document Type: Article

References (42)

1. Ali S.F., and Freyaldenhoven T. MPTP-A model of Parkinson's disease. In: Bondy S.C. (Ed). Chemicals and Neurodegenerative Disease (1999), Prominent Press, Scottsdale, AZ 161-188
2. Beatty W.W., Dodge A.M., and Traylor K.L. Stereotyped behavior elicited by amphetamine in the rat: influence of the testes. Pharmacol. Biochem. Behav. 16 (1982) 565-568
3. Becker J.B. Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol. Biochem. Behav. 64 (1999) 803-812
4. Becker J.B., and Ramirez V.D. Sex differences in the amphetamine stimulated release of catecholamines from rat striatal tissue in vitro. Brain Res. 204 (1981) 361-372
5. Bhatt S.D., and Dluzen D.E. Dopamine transporter function differences between male and female CD-1 mice. Brain Res. 1035 (2005) 188-195
6. Bitar M.S., Ota M., Linnoila M., and Shapiro B.H. Modification of gonadectomy-induced increases in brain monoamine metabolism by steroid hormones in male and female rats. Psychoneuroendocrinology 16 (1991) 547-557
7. Brooks W.J., Jarvis M.F., and Wagner G.C. Influence of sex, age and strain of MPTP-induced neurotoxicity. Res. Commun. Subst. Abuse 10 (1989) 181-184
8. Chen R., Osterhaus G., McKerchar T., and Fowler S.C. The role of exogenous testosterone in cocaine-induced behavioral sensitization and plasmalemmal or vesicular dopamine uptake in castrated rats. Neurosci. Lett. 351 (2003) 161-164
9. Crowley W.R., O'Donohue T.L., and Jacobowitz D.M. Sex differences in catecholamine content in discrete brain nuclei of the rat: effects of neonatal castration or testosterone treatment. Acta Endocrinol. (Copen) 89 (1978) 20-28
10. Czlonkowska A., Ciesielska A., Gromadzka G., and Kurkowska-Jastrzebska I. Gender differences in neurological disease: role of estrogens and cytokines. Endocrine 29 (2006) 243-256
11. Datla K.P., Murray H.E., Pillai A.V., Gillies G.E., and Dexter D.T. Differences in dopaminergic neuroprotective effects of estrogen during estrous cycle. NeuroReport 14 (2003) 47-50
12. Dluzen D.E. The effect of gender and the neurotrophin, BDNF, upon methamphetamine-induced neurotoxicity of the nigrostriatal dopaminergic system in mice. Neurosci. Lett. 359 (2004) 135-138
13. Dluzen D.E. The effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system in male C57/Bl mice. Brain Res. 715 (1996) 113-119
14. Dluzen D.E. Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic neurons. J. Neurocytol. 29 (2000) 387-399
15. Dluzen D.E., Anderson L.I., and Pilati C.F. Methamphetamine-gonadal steroid interactions: effects upon acute toxicity and striatal dopamine concentrations. Neurotox. Teratol. 24 (2002) 267-273
16. Dluzen D.E., Disshon K.A., and McDermott J.L. Estrogen as a modulator of striatal dopaminergic neurotoxicity. In: Marwah J., and Teitelbaum H. (Eds). Advances in Neurodegenerative Disorders, vol. 1: Parkinson's Disease (1998), Prominent Press, Scottsdale, AZ 149-192
17. Dluzen D.E., Green M.A., and Ramirez V.D. The effect of hormonal condition on dose-dependent amphetamine-stimulated behaviors in the male rat. Horm. Behav. 20 (1986) 1-6
18. Dluzen D.E., and Horstink M.W.I.M. Estrogen as a neuroprotectant of nigrostriatal dopaminergic system. Endocrine 21 (2003) 67-75
19. Dluzen D.E., and McDermott J.L. Estrogen and anti-estrogen and gender differences in methamphetamine neurotoxicity. Ann. NY Acad Sci. 965 (2002) 136-156
20. Dluzen D.E., and McDermott J.L. Estrogen, testosterone and methamphetamine toxicity. Ann. NY. Acad. Sci. 1074 (2006) 282-294
21. Dluzen D.E., and Ramirez V.D. Effects of orchidectomy on nigro-striatal dopaminergic function: behavioral and physiological evidence. J. Neuroendocrinol. 1 (1989) 285-290
22. Dluzen D.E., Tweed C., Anderson L.I., and Laping N.J. Gender differences in methamphetamine-induced mRNA associated with neurodegeneration in the mouse nigrostriatal dopaminergic system. Neuroendocrinology 77 (2003) 232-238
23. Engel J., Ahlenius S., Almagren O., Carlsson A., Larsson K., and Sodersten P. Effects of gonadectomy and hormone replacement on brain monoamine synthesis in male rats. Pharmacol. Biochem. Behav. 10 (1979) 149-154
24. Ekue A., Boulanger J.F., Morissette M., and Di Paolo T. Lack of effect of testosterone and dihydrotestosterone compared to 17beta-oestradiol in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-mice. J. Neuroendocrinol. 19 (2002) 731-736
25. Fernandez-Ruiz J., de Miguel R., Hernandez M.L., Cebeira M., and Ramos J.A. Comparisons between brain dopaminergic neurons of juvenile and adult rats: sex-related differences. Mech. Aging Dev. 63 (1992) 45-55
26. Freyaldenhoven T.E., Cadet J.L., and Ali S.F. The dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in CD-1 mice are gender dependent. Brain Res. 735 (1996) 232-238
27. Gajjar T., Anderson L.I., and Dluzen D.E. Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system. J. Neural. Transm. 110 (2003) 1215-1224
28. Gao X., and Dluzen D.E. The effect of testosterone upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system. Brain Res. 892 (2001) 63-69
29. Gillies G.E., Murray H.E., Dexter D., and McArthur S. Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease. Pharmacol. Biochem. Behav. 78 (2004) 513-522
30. Hall J.N., and Broderick P.M. Community networks for response to abuse outbreaks of methamphetamine and its analogs. NIDA Res. Monogr. 115 (1991) 109-120
31. Heller A., Bubula N., Lew R., Heller B., and Won L. Gender-dependent enhanced adult neurotoxic response to methamphetamine following fetal exposure to the drug. J. Pharmacol. Exp. Ther. 298 (2001) 769-779
32. Hernandez L., Gonzalez L., Murzi E., Paez X., Gottberg E., and Baptista T. Testosterone modulates mesolimbic dopaminergic activity in male rats. Neurosci. Lett. 171 (1994) 172-174
33. Long S.F., Dennis L.A., Russell P.K., Benson K.A., and Wilson M.C. Testosterone implantation reduces the motor effects of cocaine. Behav. Pharmacol. 5 (1994) 103-106
34. McDermott J.L., Liu B., and Dluzen D.E. Sex differences and effects of estrogen on dopamine and DOPAC release from the striatum of male and female CD-1 mice. Exp. Neurol. 125 (1994) 306-311
35. Menniti F.S., and Baum M.J. Differential effects of estrogen and androgen on locomotor activity induced in castrated rats by amphetamine, a novel environment, or apomorphine. Brain Res. 216 (1981) 89-107
36. Miller D.B., Ali S.F., O'Callaghan J.P., and Laws S.C. The impact of gender and estrogen on striatal dopamine neurotoxicity. Ann. NY Acad. Sci. 844 (1998) 153-165
37. Murray H.E., Pillai A.V., McArthur S.R., Razvi N., Datla D.T., and Gillies G.E. Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathways of adult rats: Differences in action of estrogen in males and females. Neuroscience 116 (2003) 213-222
38. Savageau M.M., and Beatty W.W. Gonadectomy and sex differences in the behavioral responses to amphetamine and apormorphine of rats. Pharmacol. Biochem. Behav. 14 (1981) 17-22
39. Shulman L.M., and Bhatt V. Gender disparities in Parkinson's disease. Expert Rev. Neurother. 6 (2006) 407-416
40. Wagner G.C., Tekirian T.L., and Cheo C.T. Sexual differences in sensitivity to methamphetamine toxicity. J. Neural Transm. Gen Sect. 93 (1993) 67-70
41. Yu L., and Liao P.C. Sexual differences and estrous cycle in methamphetamine-induced dopamine and serotonin depletions in the striatum of mice. J. Neural Transm. 107 (2000) 419-427
42. Yu Y.-L., and Wagner G.C. Influence of gonadal hormones on sexual differences in sensitivity to methamphetamine-induced neurotoxicity. J. Neural Transm. [P-D Sect] 8 (1994) 215-221 [P-D Sect]